Literature DB >> 6264129

Partial expression of endogenous mouse mammary tumor virus in mammary tumors induced in BALB/c mice by chemical, hormonal, and physical agents.

J S Butel, S Dusing-Swartz, S H Socher, D Medina.   

Abstract

The possible interaction of environmental factors with the endogenous mouse mammary tumor virus (MMTV) genome in the development of mammary tumors in the low-tumor-incidence BALB/c mouse strain was examined. Tumors were induced in virgin female animals by treatment with chemical carcinogen 7,12- dimethylbenz[alpha]anthracene or urethan, with or without prolonged hormonal stimulation, or by X-irradiation. Concomitant hormonal stimulation resulted in increased tumor incidences compared with those induced by chemical carcinogen treatment alone. The frequency of tumor induction by irradiation alone or in combination with urethan or prolactin stimulation was very low. MMTV expression in the mammary tumors was assayed by nucleic acid hybridization and by immunohistochemical staining. Depending upon the treatment group, 0 to 89% of the tumors contained detectable levels of MMTV RNA (>/=0.0005% of the total cellular RNA). Tumors which contained detectable viral transcripts exhibited only low levels of MMTV RNA, which did not appear to represent the accumulation of RNA sequences homologous to the entire MMTV genome; synthesis of MMTV structural proteins was detected in only one tumor. Viral RNA-positive tumors were generally associated with a longer latent period. MMTV RNA expression occurred in tumors classified histologically as adenoacanthomas, as well as in mammary adenocarcinomas, although the cell types in the adenoacanthomas expressing viral RNA were not identified. It does not appear that expression of the endogenous MMTV genome is required for maintenance of all mammary tumors in BALB/c mice, although partial genome expression undetectable by the methods employed cannot be ruled out. Linear regression analyses were performed. The mean time to tumor appearance and the percentage of tumors which were MMTV RNA positive were found to vary linearly as a function of the total dose of 7,12-dimethylbenz[alpha]anthracene administered. The percentage of tumors which were MMTV RNA positive was also shown to be linearly related to the mean time to tumor appearance. These relationships provide a basis for predictions in the BALB/c system related to these parameters.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6264129      PMCID: PMC171188     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  Comparison of mouse mammary tumor virus-specific DNA in inbred, wild and Asian mice, and in tumors and normal organs from inbred mice.

Authors:  V L Morris; E Medeiros; G M Ringold; J M Bishop; H E Varmus
Journal:  J Mol Biol       Date:  1977-07       Impact factor: 5.469

2.  Changes in MuMTV DNA and RNA levels in Balb/c mammary epithelial cells during malignant transformation by exogenous MuTV and by hormones.

Authors:  C M McGrath; E J Marineau; B A Voyles
Journal:  Virology       Date:  1978-06-15       Impact factor: 3.616

3.  Interactions between viral and genetic factors in the origin of mammary tumors in mice.

Authors:  P Bentvelzen; J H Daams; P Hageman; J Calafat; A Timmermans
Journal:  J Natl Cancer Inst       Date:  1972-04       Impact factor: 13.506

4.  Kinetic studies of gene frequency. II. Complexity of globin complementary DNA and its hybridization characteristics.

Authors:  B D Young; P R Harrison; R S Gilmour; G D Birnie; A Hell; S Humphries; J Paul
Journal:  J Mol Biol       Date:  1974-04-25       Impact factor: 5.469

5.  Mammary tumorigenesis in chemical carcinogen-treated mice. I. Incidence in BALB-c and C57BL mice.

Authors:  D Medina
Journal:  J Natl Cancer Inst       Date:  1974-07       Impact factor: 13.506

6.  A comparative study of the biologic and molecular basis of murine mammary carcinoma: a model for human breast cancer.

Authors:  J Schlom; R Michalides; D Kufe; R Hehlmann; S Spiegelman; P Bentvelzen; P Hageman
Journal:  J Natl Cancer Inst       Date:  1973-08       Impact factor: 13.506

7.  Evidence of separate pathways for viral and chemical carcinogenesis in C3H/StWi mouse mammary glands.

Authors:  G H Smith; L A Arthur; D Medina
Journal:  Int J Cancer       Date:  1980-09-15       Impact factor: 7.396

8.  Assay of DNA-RNA hybrids by S1 nuclease digestion and adsorption to DEAE-cellulose filters.

Authors:  I H Maxwell; J Van Ness; W E Hahn
Journal:  Nucleic Acids Res       Date:  1978-06       Impact factor: 16.971

Review 9.  Host-virus interactions in murine mammary carcinogenesis.

Authors:  P Bentvelzen
Journal:  Biochim Biophys Acta       Date:  1974-12-31

10.  Differences in mouse mammary tumor viruses. Relationship to early and late occurring mammary tumors.

Authors:  J Schlom; D Colcher; W Drohan; R Kettmann; R Michalides; G Vlahakis; J Young
Journal:  Cancer       Date:  1977-06       Impact factor: 6.860

View more
  5 in total

1.  Anti-growth action on mouse mammary and prostate glands of a monoclonal antibody to prolactin receptor.

Authors:  J F Sissom; M L Eigenbrodt; J C Porter
Journal:  Am J Pathol       Date:  1988-12       Impact factor: 4.307

2.  Direct detection of exogenous mouse mammary tumor virus sequences in lymphoid cells of BALB/cfC3H female mice.

Authors:  T J Liegler; P B Blair
Journal:  J Virol       Date:  1986-07       Impact factor: 5.103

3.  Transcription of mouse mammary tumor virus: identification of a candidate mRNA for the long terminal repeat gene product.

Authors:  D A Wheeler; J S Butel; D Medina; R D Cardiff; G L Hager
Journal:  J Virol       Date:  1983-04       Impact factor: 5.103

4.  Proviral unit II of endogenous mouse mammary tumour virus is selectively amplified and expressed in C57B1/10 mammary tumours induced by non-viral carcinogens.

Authors:  J Svec
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

5.  Identification and characterization of a mouse mammary tumor virus protein uniquely expressed on the surface of BALB/cV mammary tumor cells.

Authors:  B L Slagle; J S Butel
Journal:  Virology       Date:  1985-05       Impact factor: 3.616

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.